
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 24 years ago
Role of hs-CRP in Cardiovascular Risk Predictionover 24 years ago
Changes in ATP III focus on diabetes and the metabolic syndromeover 24 years ago
Role of managed care in implementing NCEP-ATP III guidelinesover 24 years ago
Aggressive Lipid Reduction Provides Additional Clinical Benefit


